Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells

Osteosarcoma is the most common primary malignant bone tumor. Although cisplatin is the primary chemotherapy used in osteosarcoma treatment, the cisplatin resistance remains a big challenge for improving overall survival. The store-operated calcium (Ca(2+)) entry (SOCE) and its major mediator Stim1...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xilong, Wei, Qiang, Cheng, Jie, Bian, Yanzhu, Tian, Congna, Hu, Yujing, Li, Huijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486860/
https://www.ncbi.nlm.nih.gov/pubmed/28326487
http://dx.doi.org/10.1007/s13577-017-0167-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486860/
https://www.ncbi.nlm.nih.gov/pubmed/28326487
http://dx.doi.org/10.1007/s13577-017-0167-9

Ejemplares similares